(Q44261071)

English

Delayed treatment with MLN519 reduces infarction and associated neurologic deficit caused by focal ischemic brain injury in rats via antiinflammatory mechanisms involving nuclear factor-kappaB activation, gliosis, and leukocyte infiltration

scientific article published in January 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Delayed treatment with MLN519 reduces infarction and associated neurologic deficit caused by focal ischemic brain injury in rats via antiinflammatory mechanisms involving nuclear factor-kappaB activation, gliosis, and leukocyte infiltration (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

author name string

Anthony J Williams

1

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Sarah L Hale

2

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

John R Moffett

3

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Jitendra R Dave

4

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Peter J Elliott

5

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Julian Adams

6

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Frank C Tortella

7

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

publication date

1 January 2003

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Journal of Cerebral Blood Flow & Metabolism

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

23

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

75-87

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination

1 reference

https://api.crossref.org/works/10.1097%2F00004647-200301000-00008

21 January 2018

Drug-induced neuroprotection from global ischemia is associated with prevention of persistent but not transient activation of nuclear factor-kappaB in rats

1 reference

https://api.crossref.org/works/10.1097%2F00004647-200301000-00008

21 January 2018

Background review and current concepts of reperfusion injury

1 reference

https://api.crossref.org/works/10.1097%2F00004647-200301000-00008

21 January 2018

The contribution of reoxygenation to ischemic brain damage

1 reference

https://api.crossref.org/works/10.1097%2F00004647-200301000-00008

21 January 2018

Ischemic core and penumbra in human stroke

1 reference

https://api.crossref.org/works/10.1097%2F00004647-200301000-00008

21 January 2018

Role of Neutrophils in Radical Production during Ischemia and Reperfusion of the Rat Brain: Effect of Neutrophil Depletion on Extracellular Ascorbyl Radical Formation

1 reference

https://api.crossref.org/works/10.1097%2F00004647-200301000-00008

21 January 2018

Clinical experience with excitatory amino acid antagonist drugs

1 reference

https://api.crossref.org/works/10.1097%2F00004647-200301000-00008

21 January 2018

Delayed treatment with an adenosine kinase inhibitor, GP683, attenuates infarct size in rats with temporary middle cerebral artery occlusion

1 reference

https://api.crossref.org/works/10.1097%2F00004647-200301000-00008

21 January 2018

Identifiers

10.1097/00004647-200301000-00008

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44261071&oldid=2108968916"